查看完整行情页>>

|

货币单位:美元(USD)

OncoCyte Corp. (ocx)

实时(?):
盘后(?):
读取中...
  • -- (--%)
开盘价:-- 最高价:-- 最低价:-- 52周最高价:-- 52周最低价:--
成交量:-- 平均成交量:-- 市值:-- 市盈率:-- 预期市盈率:--
每股收益:-- 贝塔系数:-- 股息:-- 收益率:-- 总股本:--
Ekkehard Schütz Currently, Ekkehard Schütz is Chief Science Officer at OncoCyte Corp. and Chief Executive Officer & Chief Medical Officer at Chronix Biomedical, Inc. (a subsidiary of OncoCyte Corp.). He received a doctorate from the University of Gottingen.
Padma Sundar Padma Sundar occupies the position of Chief Commercial Officer for OncoCyte Corp. Ms. Sundar is also on the board of Smart Health Diagnostics Co. In her past career Ms. Sundar was Vice President-Strategy & Market Access at Cellmax, Inc., Director-Marketing at Guardant Health, Inc. and Senior Director-Oncology at Affymetrix, Inc. Ms. Sundar received an MBA from the University of California and an undergraduate degree from the University of Delhi.
Joshua Riggs Joshua Riggs is President, Chief Executive Officer & Director at OncoCyte Corp. In his past career he held the position of Principal at Bethesda Group LLC.
Andrew Arno Andrew Arno is a businessperson who founded Unterberg Capital LLC and who has been the head of 9 different companies. Mr. Arno is Chairman of OncoCyte Corp. and Chairman, CEO, CFO & Secretary at ComHear, Inc. He is also on the board of Smith Micro Software, Inc., 22nd Century Group, Inc., Independa, Inc. and New York Service for the Handicapped and Treasurer & Director at The Jewish Community Center in Manhattan, Inc. In his past career Mr. Arno held the position of President of Lomusa Ltd., Vice President at Sabr Group, Inc., Vice Chairman & Chief Marketing Officer at Unterberg Capital LLC, Chairman & Chief Executive Officer of C. E. Unterberg, Towbin Advisors LP, Chairman & Chief Executive Officer at C. E. Unterberg, Towbin, Inc., Chairman & Chief Executive Officer of Collins Stewart LLC, Chairman for Collins Stewart LLC (Investment Management), Managing Director at Emerging Growth Equities Ltd., President at Loewen, Ondaatje, McCutcheon USA Ltd., Vice President of Lehman Brothers, Inc., Vice Chairman & Head-Equity Capital Markets at Merriman Capital, Inc. and Vice President for L. F. Rothschild, Unterberg, Towbin, Inc. He received an undergraduate degree from George Washington University.
Yuh-Min Chiang Yuh-Min Chiang holds the position of Senior Vice President-Research & Development at OncoCyte Corp. In the past Dr. Chiang was Chief Technology Officer of Alveo Technologies, Inc.
Andrew J. Last Andrew J. Last is Chief Operating Officer & Executive Vice President of Bio-Rad Laboratories, Inc. He is also on the board of OncoCyte Corp. He previously was Chief Operating Officer at Precigen, Inc., VP-Global Marketing & Strategic Planning at Becton, Dickinson & Co. and General Manager for PharMingen (a subsidiary of Becton, Dickinson & Co.), Director-Ortho Home & Garden at The Solaris Group, Vice President & General Manager at Applied Biosystems, Inc. and Vice President & GM-Gene Expression Business at Applera Corp. (a subsidiary of Applied Biosystems, Inc.), Vice President-Global & Strategic Marketing at BD Biosciences, Systems & Reagents, Inc., Chief Operating Officer & Executive Vice President for Affymetrix, Inc., Director-Worldwide Business at Monsanto Co. and Chief Commercial Officer for Berkeley Lights, Inc. He received a doctorate and a graduate degree from Cranfield University and an undergraduate degree from the University of Leicester.
Alfred Dennis Kingsley Alfred Dennis Kingsley is a businessperson who has been at the helm of 10 different companies and presently is Chairman for Lineage Cell Therapeutics, Inc., Executive Chairman at ES Cell International Pte Ltd., Executive Chairman for OrthoCyte Corp. and Executive Chairman for BioTime Asia Ltd. (which are all subsidiaries of Lineage Cell Therapeutics, Inc.) and President at Greenbelt Corp., General Partner at Greenway Partners LP (a subsidiary of Greenbelt Corp.). Alfred Dennis Kingsley is also on the board of ReCyte Therapeutics, Inc., Cell Cure Neurosciences Ltd., OncoCyte Corp. (former Director) and Ascendance Biotechnology, Inc. In the past he held the position of Independent Director at Asterias Biotherapeutics, Inc., Chairman at AgeX Therapeutics, Inc. and Senior Vice President of Icahn & Co., Inc. Mr. Kingsley received an undergraduate degree from The Wharton School of the University of Pennsylvania and a graduate degree from New York University School of Law.
Louis E. Silverman Louis E. Silverman is a businessperson who has been at the head of 5 different companies. Mr. Silverman holds the position of Chairman & Chief Executive Officer of Advanced ICU Care, Inc. He is also on the board of PatientPay, Inc., Central Maine Healthcare Corp. and OncoCyte Corp. Mr. Silverman previously occupied the position of Chairman of Comarco, Inc., Independent Director at STAAR Surgical Co., President & Chief Executive Officer of NextGen Healthcare, Inc., Chief Operating Officer at CorVel Corp., Chief Executive Officer-LifeComm Division at QUALCOMM, Inc. and Chief Executive Officer for Marina Medical Billing Services, Inc. Mr. Silverman received an undergraduate degree from Amherst College and an MBA from Harvard Business School.